Non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full thickness cartilage defects in the hip.
Prospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with impingement syndrom in the hip. Safety: 24-month post treatment follow up period by measuring the number of adverse drug reactions/serious adverse drug reactions. Efficacy: 24-month post treatment follow up period using iHOT 33 and EuroQuol-5D-5L.
Study Type
OBSERVATIONAL
Enrollment
21
University Hospital Carl Gustav of TU Dresden
Dresden, Germany
Essen University Hospital
Essen, Germany
sporthopaedicum Straubing
Straubing, Germany
Number of adverse drug reactions/serious adverse drug reactions as a measurement of safety.
Number of adverse drug reactions/serious adverse drug reactions as a measurement of safety.
Time frame: 12 months
Number of adverse drug reactions/serious adverse drug reactions as a measurement of safety.
Number of adverse drug reactions/serious adverse drug reactions as a measurement of safety.
Time frame: 24 months
iHOT 33 (international HIP Outcome Tool) as a measurement of function and Quality of life
Outcome of iHOT 33 as a measurement of function and Quality of life
Time frame: 12 and 24 months
EQ-5D-5L (5-level EQ-5D ) as a measurement of function and Quality of life
Outcome of EQ-5D-5L as a measurement of function and Quality of life
Time frame: 12 and 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.